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The report by Carlsen et al. (1) that mean
sperm counts in some men had declined by
around 40-50% over the past 50 years was
greeted with a mixture of concern (2) and
skepticism (3). The most recent data from a
number of countries, which have charted
changes in sperm counts in semen donors
over the past 20-25 years, have, however,
all reported a marked and significant down-
ward trend (4-6). The most comprehensive
of these studies, in Paris, concluded that
sperm counts in fertile men have declined
by around 2% per year over the past 23
years (6). Moreover, two ofthe cited studies
(5,6) identified that the temporal decline in
sperm counts appears to apply to men born
from around 1950 onwards.
Two years ago, we hypothesized (7) that
the reported decline in sperm counts might
be related to an increasing incidence of
other disorders ofdevelopment ofthe male
reproductive system (e.g., testicular cancer)
and that this could have arisen because of
increased exposure of the developing fetus
to estrogens. One potential source of this
increased estrogen exposure was via envi-
ronmental estrogenic chemicals, or "xenoe-
strogens," the release ofwhich has more or
less coincided with the decline in sperm
counts (8,9). Concern about such hormon-
ally active pollutants, such as chlorinated
pesticides, has been voiced for 10-20 years
(10), but has become more acute recently
because of the discovery of a range of new
xenoestrogens, including bisphenol-A (11),
certain alkylphenolic chemicals (12-14),
certain phthalates (15), as well as a number
ofpesticides (16). Most ofthese estrogenic
chemicals are ubiquitous in the environ-
ment, and humans are exposed to them
daily by a number of routes (9). However,
the risk to humans from these chemicals is
currently theoretical because there are no
data to show that these chemicals can cause
any disorder of reproductive development
or function in animals.
Pathways via which exposure of the
developing male fetus or neonate to estro-
genic chemicals could result in reduced tes-
ticular size and sperm production in adult
life have been identified (2,7,9), but there is
no direct evidence to confirm whether this
hypothesis has any factual basis. It is known
that some phthalates are passed from the
mother both across the placenta (17) and via
milk (18), although comparable data on the
transfer of alkylphenolic chemicals are lack-
ing. The aim of the present studies was to
evaluate whether exposure of the male rat
fetus/neonate to either oftwo environmental
estrogenic chemicals has any effect on testic-
ular size and spermatogenesis in adult life.
Material and Methods
Animals and treatments. All rats used in
these studies were of the Wistar strain and
were bred in our own animal facility. They
were maintained under standard, controlled
conditions and had free access to food and
water. Administration of chemicals was via
the drinking water, which was provided in a
bottle per cage. A stock solution of each
dose ofchemicals was made by dissolving a
weighed amount in ethanol such that addi-
tion of0.5 ml ofthis stock to 51 of tapwa-
ter resulted in the test dose; control animals
had 0.5 ml ethanol/5 added to their drink-
ing water.
Study design. The most likely mecha-
nism via which estrogenic chemicals could
cause an irreversible reduction in testicular
size and sperm production is by decreasing
the number ofSertoli cells. In adult life, the
number ofSertoli cells determines testicular
size and sperm production in all animals
that have been studied (19). In the male rat,
Sertoli cells begin to proliferate soon after
testicular differentiation (about day 1 5 of
gestation) and continue until around day
15 of postnatal life, with perhaps minor
proliferation until around day 21; after this
time, no further Sertoli cell proliferation
can occur (19). Thus, by day 22, the ulti-
mate size to which the testis will grow in
adulthood (90-95 days of age) has been
predetermined (19L22).
Our studies were designed such that
animals were exposed to chemicals for
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either the postnatal period (i.e., days 1-22
after birth) of Sertoli cell proliferation
(study 1; see Fig. 1) or for the complete
period ofSertoli cell proliferation (studies 2
and 3; see Fig. 1). In the latter two studies,
treatments were administered to adult
female rats for 2 weeks before mating with
a sexually experienced male, throughout
mating, throughout gestation, and up until
day 22 after giving birth (Fig. 1). This pro-
tocol of exposure was used to assess the
possible effects of bioaccumulation. In all
three studies, exposure of the male off-
spring to the test chemicals was thus largely
indirect, via the placenta or milk.
In study 1, in which there was no pre-
natal exposure to the test chemicals, litters
were culled to eight pups on the day of
birth (day 1) by culling excess females. The
same was done in study 2. In study 3, the
full litter size was maintained from birth
through day 22. The female offspring of
test litters were not evaluated. Adult
females used for mating in studies 2 and 3
were the same: when offspring of these
females were weaned at the completion of
study 2, the mothers were maintained on
the same treatment for 2 weeks, then
mated and exposed until the weaning of
study 3 offspring (Fig. 1).
Test chemicals and doses. Three chemi-
cals were selected for study based on the
results of in vitro investigations suggesting
that they were estrogenic (13-15). Of the
three, 4-tert-octylphenol (OP; Aldrich
Chemical Co., Gillingham, UK) and butyl
benzyl phthalate (BBP; Chem Service,
West Chester, Pennsylvania) were both
estrogenic in vitro, whereas an octylphenol
polyethoxylate withl a side-chain of five
ethoxylate groups (OPP; Igepal C
Aldrich) was essentially devoid c
genicity in vitro. In study 1, nonylp
carboxylic acid (NPIEC, K &
Cleveland, Ohio), which is appro.
10-fold less estrogenic in vitro tr
(14), was also assessed at a sing
Diethylstilbestrol (DES; Sigma C
Co., Poole, Dorset, UK), which is
nonsteroidal estrogen, was incluc
positive control.
Little is known about the d4
exposure of humans to the chemic
in the present studies, but concer
ofalkylphenolic compounds in the
environment reportedly range up
dreds of micrograms per milliliter
whereas human intake of phtho
reportedly as high as 15 mg I
(200-300 pg/kg/day) (25). There
chose doses that would be mildl
genic based on in vitro analyses
but which remained within an c
magnitude of the possible e]
mental/human intake level. We te
at 1000 and 100 pg/l in all three
(and also at 10 pg/l in study 1),
OPP and BBP were tested only at
gle dose of 1000 pg/l in studies 2
DES was tested at 100 and 10 pg/l
1 and at 100 pg/l in studies 2 ano
formal confirmation that the test cl
(or their metabolites) actually rea
male offspring, or in what amou
obtained, as the objective was si
establish whether or not the ch
exerted any biological effects. H
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Figure 1. Experimental design of the present studies, indicating the periods of treatment in relat
time of normal proliferation of Sertoli cells. After cessation of treatment (day 22 after birth) anin
maintained under normal conditions until they were kHled atthe age of90-95 days.
-0-520; ing water bottles every 48 hr.
f estro- Body andorgan weights, litter size and
henoxy- composition. In studies 2 and 3, we record-
K Labs, ed litter size and composition at birth. In
ximately all three studies, the male offspring were
han OP weighed at weaning (day 22), which was
le dose. the day that treatment ceased. The male
"hemical offspring were then maintained in their lit-
a potent ters under standard conditions until 90-95
ded as a days of age, when they were killed by
inhalation of C02, followed by cervical
egree of dislocation. Body weight was recorded and
:als used the right testis, left kidney, and ventral
itrations prostate were dissected out and weighed;
aquatic the epididymis, seminal vesicles, and left
to hun- testis were also inspected macroscopically
(23,24), for any obvious abnormalities. We record-
alates is ed kidney weight because the kidney varies
per day according to body weight but was not
fore, we expected to be affected by the experimental
ly estro- manipulations. The kidney was thus used
(14,15), as an internal "organ control" for the speci-
order of ficity ofany effects observed on testis size.
nviron- Testicular morphology. At 90-95 days
sted OP ofage, representative animals from the var-
studies ious treatment groups were fixed with 3%
whereas glutaraldehyde in 0.2 M cacodylate buffer
the sin- by perfusion via the dorsal aorta, as
2 and 3. described elsewhere (26). The fixed testes
in study were then cut transversely with a razor
d 3. No blade into 2-mm-thick sections and then
hemicals into small blocks (1-2 mm2). After postfix-
:hed the ation for 12-16 hr in the same fixative, the
nts, was blocks were processed and embedded in
mply to plastic as described previously (26). Semi-
emicals thin sections (0.5 pm) were then cut,
lowever, stained with toluidine blue, and examined
al intake using a Zeiss photomicroscope.
some of To provide a preliminary quantitative
y weigh- assessment of spermatogenesis, seminifer-
ous tubules at stages VII-VIII of the sper-
matogenic cycle were subjected to image
analysis (Cue-2, Olympus) to determine
the cross-sectional area of the seminiferous Fi tubule and seminiferous epithelium (27.
We analyzed 10 round cross-sections for
two or three rats per treatment group and
calculated the mean and standard deviation
for each animal. Stages VII-VIII were cho-
sen for analysis because they contain repre-
sentative germ cells from all steps ofdevel-
opment (19).
Daily spermproduction. In some ofthe
animals from study 3, daily sperm produc-
tion was determined by counting homoge-
nization-resistant spermatids, using minor
modifications ofthe techniques ofJohnson
et al. (28,29). A 500-700 mg portion of
testicular tissue recovered at autopsy was
Weanina immersion-fixed in 2% glutaraldehyde in
(Day22Y 0.2 M cacodylate buffer and kept at 40C
tion to the until used for daily sperm production
nals were determination within the next 6 weeks.
The tissue was then removed, blotted, and
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weighed and two 50-mg portions cut with
a scalpel, weighed, and homogenized sepa-
rately in 5 ml 0.15 M NaCl, 0.05%
Triton-X100, 0.025% sodium azide, using
a Polytron homogenizer (PT-K/PCU-8;
Kinematica AG, Luzern, Switzerland) at
speed 5 for 60 sec (these conditions had
previously been validated and optimized).
Using a hemocytometer, homogenization-
resistant step 18 and 19 spermatids were
then counted separately in 3 aliquots of
each ofthe 2 homogenates per sample and
the mean of the 6 measurements calculat-
ed; the coefficient of variation for these
replicates averaged 7% for all samples. This
value was then corrected for sample weight
and overall testis weight, and transformed
to the daily sperm production by dividing
by the appropriate time divisor (4.61)
based on the proportional duration of
stages VI-VIII in days, according to
Leblond and Clermont (30). We con-
firmed that only step 18 and 19 spermatids
were being counted by applying the same
procedures to known lengths of seminifer-
ous tubule isolated from normal adult rats
by transillumination-assisted microdissec-
tion (31) at stages II-V (containing step 16
and 17 spermatids) and VI-VIII (contain-
ing step 18 and 19 spermatids).
Statisticalanalysis. In each ofthe three
studies, each parameter in the different
treatment groups was subjected to analysis
of variance to determine whether there
were significant effects oftreatment. Where
these were indicated, subgroup compar-
isons between means for the control and
each treatment group were made using the
variance from the study as a whole as the
measure of error. All data were normally
distributed, so no transformations were
made, and results are all reported as means
± SD.
Results
Litter size and composition at birth were
not evaluated in study 1, as there was no
prenatal treatment ofthe mothers. In stud-
ies 2 and 3, in which the mothers were
treated prenatally, there was no effect of
treatment with OP, OPP, or BBP, on litter
size or composition. Exposure to DES (100
jig/l) reduced average litter size by nearly
halfin study 3 and had a more minor effect
in study 2 (Table 1). Curiously, the pro-
portion ofmale offspring was increased sig-
nificantly in the DES-exposed group in
study 3 (Table 1).
At weaning, which corresponded to the
cessation of treatment in all three studies,
body weight of DES-exposed offspring was
reduced significantly in studies 1 and 2 but
was increased significantly in study 3, per-
haps because ofthe much smaller lirter sizes
(Table 1). Otherwise, exposure to any ofthe
test chemicals had either no effect or, more
commonly, resulted in a significant increase
in bodyweight on day22 (Table 1).
In study 1, mean body weight was gen-
erally higher in treatment groups, com-
pared with controls, but only in the case of
OP (100 pg/I) did this reach statistical sig-
nificance (Table 2). Average testis weight
was reduced marginally, but significantly,
in animals exposed to DES (100 pg/l) and
OP (1000 pg/l), and relative testis weight
(i.e., relative to body weight or to kidney
weight) was reduced significantly in these
two groups and in animals exposed to the
intermediate concentration (100 pg/l) of
OP (Table 2). Kidneyweight was increased
markedly in animals exposed to the two
highest doses ofOP and, although this may
have been due to some extent to the greater
average body weight of the animals, a sig-
nificant difference in kidneyweight relative
to bodyweightwas still evident (Table 2).
In study 2, mean body weight in ani-
mals exposed to DES or OPP was reduced
when compared to controls, whereas ani-
mals exposed to either dose of OP were
increased in size by 8% or more (Table 3).
Except for animals exposed to the lower
dose of OP (100 pg/I), all other treatment
groups exhibited a highly significant
decrease in absolute testis weight and in the
ratio of testis/kidney size (Table 3); all
treatment groups showed a significant
decrease in relative testis weight. There
were some minor, but significant, changes
in absolute and relative kidney weight in
some of the treatment groups. Ventral
prostate weight was reduced by 16% in
DES-treated animals, though this effect
largely disappeared when the size relative to
body weight was evaluated (Table 3).
Table 1. Litter size and composition at birth and bodyweight on day 22 (means + SD)
Treatment Litter size Bodyweight(g) of males,
Study no. group (pg/I) (no. oflitters) % Males at birth day 22 (n)
1 Control ND ND 60± 8 (70)
DES(100) ND ND 55± 7**(46)
DES (10) ND ND 54± 5t(48)
OP(0 00) ND ND 60± 5 (56)
OP (100) ND ND 65 ±6t (35)
OP (10) ND ND 65±9**(34)
Nonylphenol (100) ND ND ND
2 Control 10.0 ± 2.5(5) 61 ± 8 53 ± 5 (29)
DES (100) 8.2± 1.7 (6) 64± 14 46 ±8t(30)
OP(1000) 12.0±1.1 (6) 46± 14 61 ± 8t (30)
OP (100) 10.8 ± 3.5(6) 53 ± 14 66 ± 5t (33)
OPP (1000) 10.6 ± 3.2(5) 63 ± 15 54 ± 7(39)
BBP(1000) 11.6 ±3.4(5) 64± 13 59± 7**(38)
3 Control 12.7 ± 2.2(6) 55 ± 12 50 ± 10(36)
DES (100) 6.2 ± 3.3 (5)** 80 ± 20* 57 ± 8**(27)
OP(I000) 11.2±1.8(5) 64±7 52±8(39)
OP (100) 10.8 ± 2.1 (6) 57 ± 13 54 ± 7*(36)
OPP(1000) 13.8 ± 0.4(6) 45±11 47± 4(34)
BBP (1000) 13.4 ± 1.5(5) 57 ± 3 57± 8**(38)
Abbreviations: DES, diethylstilbestrol; OP, octylphenol; OPP, octylphenol polyethoxylate; ND, not deter-
mined.
*p<0.05,
** p<0.01,tp<0.001, compared to respective control value.
Table 2. Effect of exposure of male rats, from birth to day 22, to diethylstilbestrol, octylphenol, or nonylphe-
noxyacetic acid added tothe drinking water(pg/I) on bodyweight,testis, and kidneyweight(means ± SD)
at age 90-95 days (study 1)
Relative organ weight
Treatment Body Testis Kidney Testis/kidney (mg/g bodyweight)
group (pg/l)a N weight(g) weight(mg) weight(mg) weight ratio Testis Kidney
Control 65 504±66 1968 ± 163 1739 ± 172 1.14±0.14 3.85± 0.38 3.39± 0.32
DES(100) 36 516 ±33 1894±218* 1797 ± 124 1.06 ±0.16* 3.69± 0.49* 3.49± 0.20
DES(10) 44 506 ±40 1961 ± 147 1732± 131 1.16± 0.09 3.89± 0.34 3.37± 0.24
OP(O000) 49 518 ±34 1898 ± 130* 1883 ±223t 1.02 ±0.12t 3.68± 0.23** 3.64 ±0.38**
OP(100) 29 556 ±37t 1990± 126 1968 ±165t 1.02 ±0.1Ot 3.60± 0.34** 3.54± 0.23*
OP(10) 27 511 ±39 1940±132 1776±164 1.10±0.11 3.82±0.38 3.48±0.27
NPA(100) 33 522±45 1955 ±203 ND ND 3.75± 0.26 ND
Abbreviations: DES, diethylstilbestrol; OP, octylphenol; NPA, nonylphenoxyacetic acid; ND, not deter-
mined.
aLitters were culled to eight pups on the day of birth.
*p<0.05, **p<0.01, tp<0.001 compared to respective control value.
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Table 3. Effect of exposure of male rats, throughout gestation and until postnatal day 22,to diethylstilbestrol, octylphenol, octylphenol polyethoxylate, or butyl
benzyl phthalate added to drinking water(pg/I) on bodyweight and the weights ofthetestis, kidney, and ventral prostate (means ± SD) atage 90-95 days(study2)
Organ weights (mg)
Treatment Body Ventral Testis/kidney Relative organ weight(mg/g bodyweight)
group (pg/l)a N weight(g) Testis Kidney prostate weight ratio Testis Kidney Ventral prostate
Control 26 489 ±32 2014 ± 155 1837 ± 118 468 ± 79 1.10 ± 0.08 4.12 ± 0.26 3.76± 0.19 0.96 ± 0.14
DES (100) 26 445 ± 41** 1750 ± 180t 1759 ± 158* 393+ 44** 1.00 ±0.09t 3.94± 0.34* 3.96± 0.24* 0.89± 0.11
OP (1000) 27 530 ± 53t 1899 ± 123** 1915 ± 160* 428 ± 88 0.99 ± 0.07t 3.61 ± 0.32t 3.63 ± 0.32 0.82 ± 0.19**
OP (100) 29 534 ±41t 2042 ± 179 1880 ± 112 442± 82 1.09 ± 0.10 3.84± 0.38** 3.53± 0.23** 0.84± 0.18*
OPP (1000) 32 461 ± 32* 1783 ± 137t 1796 ± 159 476 ± 103 1.00 ±0.11t 3.88± 0.30** 3.90± 0.35 1.03± 0.20
BBP (1000) 35 476 ± 28 1809 ± 126t 1830 ± 116 454 ± 84 0.99± 0.0t 3.81 ± 0.34t 3.85 ± 0.24 0.96± 0.19
Abbreviations: DES, diethylstilbestrol; OP, octylphenol; OPP, octylphenol polyethoxylate; BBP, butyl benzyl phthalate.
aLitters were culled to eight pups on the day of birth.
*p<0.05, **p<0.01, tp<0.001 compared to respective control value.
Table 4. Effect of exposure of male rats,throughout gestation and until postnatal day22, to diethystilbestrol, octylphenol, octylphenol polyethyoxylate, or butyl
benzyl phthalate added to drinking water(pg/I) on bodyweight and the weights ofthetestis, kidney, and ventral prostate (means± SD) at age 90-95 days (study3)
Organ weights (mg)
Treatment Body Ventral Testis/kidney Relative organ weight (mg/g bodyweight)
group (pg/l)a N weight (g) Testis Kidney prostate weight ratio Testis Kidney Ventral.prostate
Control 36 479 ± 26 1954 ± 118 1749 ± 169 522 ± 84 1.13 ± 0.14 4.09± 0.28 3.66± 0.33 1.08 ± 0.16
DES (100) 23 466 ±34 1847 ± 157** 1792 ± 183 387 ±83t 1.04± 0.16** 3.99± 0.45 3.85± 0.30* 0.84±0.18t
OP (1000) 37 474 ±34 1696 ± 140t 1621 ± 121** 461 ±63** 1.05 ± 0.07** 3.57± 0.23t 3.42 ±0.24t 0.98 ±0.11**
OP (100) 34 461 ± 22* 1838 ± 114** 1699 ± 121 470 ±76* 1.09 ± 0.09 4.00± 0.31 3.69± 0.22 1.03 ± 0.20
OPP (1000) 34 460 ±32* 1810 ± 110t 1710 ± 160 495 ± 65 1.07 ± 0.11* 3.95± 0.35* 3.72± 0.22 1.08 ± 0.12
BBP (1000) 35 477 ±24 1819 ±119' 1830 ± 133 486 ±63 1.01 ± 0.08t 3.82 ±0.26t 3.79 ± 0.20 1.03 ± 0.12
Abbreviations: DES, diethylstilbestrol; OP, octylphenol; OPP, octylphenol polyethoxylate; BBP, butyl benzyl phthalate.
aLitters not culled to a standard size at birth.
bLitter size, etc., also affected bytreatment(see Table 1).
*p<0.05, **p<0.01, tp<0.001 compared to respective control value.
Relative weight ofthe prostate was reduced
significantly in animals exposed to either
dose ofOP.
In study 3, animals were noticeably
smaller on average, both at weaning and at
90-95 days of age, than animals in studies
1 and 2 (Table 4). Under this regimen, no
treatment group in adult life had a larger
mean body weight than the control group,
and two ofthe groups (OP at 100 pg/l and
OPP) showed a small but significant
decrease in body weight relative to con-
trols. In all treatment groups, testis weight
was reduced significantly when compared
to controls, though when expressed relative
to body weight this difference disappeared
for the groups exposed to DES or the lower
dose of OP (Table 4). Kidney weight was
reduced noticeably in animals exposed to
1000 pg OP/I, a difference still evident
when expressed relative to body weight;
however, the testis/kidney weight ratio in
this group was still significantly lower than
that observed in the control group (Table
4). As in study 2, ventral prostate weight
was reduced significantly in DES-exposed
animals but, in study 3, a significant reduc-
tion was also obvious in animals exposed to
OP, particularly at the higher dose (Table
4).
Although exposure to the test chemicals
throughout gestation and neonatal life
resulted in fairly consistent reductions in
testis size as adults, these decreases were
only on the order of 5-13%. However,
plotting the data for testis weight against
body weight for four of the treatment
groups from studies 2 and 3 (i.e., DES, OP
at 1000 pg/l, BBP) shows that the treated
animals have a different distribution from
controls (Fig. 2). This is most evident by
noting how few of the values for treated
animals lie above the linear regression line
plotted for the control group. Although a
similar trend was evident in the DES-
exposed animals, testicular weights were far
more variable in this treatment group,
probably because of the confounding
effects ofthis treatment on litter size, etc.
Testicular morphology was indistin-
guishable in animals from the control and
treatment groups, and no obvious abnor-
malities in the seminiferous tubules, inter-
stitium, or vasculature were evident (Fig.
3). Image analysis confirmed this impres-
sion by demonstrating no adverse effect of
treatment on the cross-sectional parameters
of stage VII-VIII seminiferous tubules;
indeed, for the most part, these parameters
tended to be higher for the treated animals
than for the controls, though this is based
on a small sample size (Table 5).
Daily sperm production in control ani-
mals from study 3 averaged 24.9 ± 3.6 x
106 per testis per day (mean ± SD, n = 12),
which agrees closely with that determined
morphometrically by Wing and
Christensen (32). Animals exposed during
fetal and neonatal life to DES, OP (1000
pg/I), or BBP in study 3 all showed signifi-
cant reductions of 10-21% in the mean
daily sperm production (Fig. 4), which
were proportionately similar to the decrease
in testis weight (Table 4); tissue from ani-
mals exposed to OPP was not evaluated.
The nominal intake of chemical was
assessed in study 3 for animals in two of
the treatment groups (OP at 1000 pg/l,
BBP) based on water intake, and ranged
from around 125 pg/kg/day in the first 2
days after birth to 370 pg/kg/day just
before weaning (Table 6). As these calcula-
tions take no account of spillage, adsorp-
tion, or degradation of the chemicals
(which were not evaluated), these values for
intake can be viewed as overestimates of
the actual intake. The level ofwater intake
was not affected by treatment (Table 6).
Discussion
The purpose of the present studies was to
assess whether exposure of male rats to
known estrogenic, environmental chemi-
cals during gestation or neonatal life had
any adverse effect on testicular size and
spermatogenesis when these animals
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reached adulthood. The results are
unequivocal in showing that exposure to
such chemicals does cause a reproducible
and consistent decrease in ultimate testicu-
lar size and daily sperm production in rats,
an effect which cannot be attributed to any
obvious overt toxicity (judged by body
weight and kidney weight). Although the
chemical-induced decrease in testicular size
and daily sperm production only ranged
from 5% to 21%, this effect occurred dur-
ing a relatively short period of treatment
and after exposure to relatively low levels of
the chemicals. Previous data involving a
similar protocol of exposure of rats to the
estrogenic pesticide methoxychlor also
reported a small reduction in adult testicu-
lar size and sperm counts (33), and a recent
study in trout (34) has demonstrated inhi-
bition of testis growth in vivo after expo-
sure to estrogenic alkylphenolic chemicals.
Ultimate testicular size in all mammals
that have been investigated is determined
by the number of Sertoli cells present in
the testis, despite the fact that it is the germ
cells, rather than the Sertoli cells, which
constitute the bulk of the testis (19,21).
Each Sertoli cell can only support a fixed
number of germ cells through their devel-
opment into spermatozoa, and hence the
more Sertoli cells present, the more germ
cells present, and thus the larger the testis.
The number of Sertoli cells can be
increased or decreased experimentally in
various animals by a number oftreatments,
with corresponding changes in testicular
size and daily sperm production, and the
same relationship appears to apply to men
(1-9). Usually, when Sertoli cell number is
altered, there is little change in the cross-
sectional appearance or size ofthe seminif-
erous tubules because Sertoli cell number
affects primarily the length, not the
breadth, ofthe tubules (20,21). The num-
ber of Sertoli cells per testis is determined
by the rate and duration oftheir prolifera-
tion, which usually occurs during a precise-
ly timed period that begins in fetal life
(shortly after testicular differentiation) and
continues into neonatal life for a period
that varies according to the species (19).
In the present studies, rats were
exposed to estrogenic chemicals for either
part (study 1) or all (studies 2 and 3) ofthe
period when Sertoli cell proliferation
occurs (Fig. 1). If these treatments had
reduced the rate of Sertoli cell prolifera-
tion, we would expect that, in adult life,
the testes would be smaller and daily sperm
production will be reduced, but the cross-
sectional appearance of the seminiferous
tubules would probably be unchanged.
Our findings are consistent with the treat-
ments having reduced Sertoli cell number,
though morphometric determination of
Sertoli cell number will be necessary to
determine whether this interpretation is
correct; as the expected change in Sertoli
cell number would only be ofthe order of
2-4%, measurements in large cohorts of
animals will be necessary to demonstrate
this. However, an earlier study (35)
Figure 3. Representative testicular morphology in a control animal (A) and in rats exposed during fetal/neonatal life to diethylstilbestrol (B), 1000 pg octylphenol/l
(C), or butyl benzyl phthalate (D) in study 3. (A-D) x 62.
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Table 5. Quantitative analysis of the cross-sectional area of seminiferous tubules and the seminiferous
epithelium atstages VII-VIII ofthe spermatogenic cycle in animals from study 3a
Seminiferous Seminiferous
Treatment group (pg/I) Animal no. tubule area (x103 pm2) epithelium area (x103 pm2)
Control 1 77 ±9 56 ±6
2 71±9 51±6
DES (100) 1 94± 11 69 ±6
2 89±12 68±8
0P(1000) 1 79±7 58±5
2 74±6 56±5
3 76±9 61 ±6
OPP(1000) 1 83±9 61 ±8
2 86± 12 63±8
BBP(1000) 1 86±11 62±8
2 86±9 64±7
Abbreviations: DES, diethylstilbestrol; OP, octylphenol; OPP, octylphenol polyethoxylate; BBP, butyl benzyl
phthalate.
aRats were exposed to chemical via drinking water throughout gestation and until postnatal day 22. Data
are the means ± SD for 10 seminiferous tubules per animal and were based on analysis of perfusion-fixed
tissue. Because ofthe small numbers of animals, no statistical analysis ofthese data was attempted.
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Figure 4. Daily sperm production (means ± SD) in
representative control animals (n =12) and in rats
exposed during fetal/neonatal life to diethyl-
stilbestol (DES; n = 7), octylphenol (1000 pg/l; n =
18) or butyl benzyl phthalate (BBP; n = 7) in study
3. *p<0.05, **p<0.01, tp<0.001 compared to con-
trol.
demonstrated that exposure ofrats to di(2-
ethylhexyl)phthalate for 5 days during
neonatal life resulted in a reduction in
Sertoli cell number and some reduction in
testis size and sperm production in adult-
hood; however, the level ofphthalate expo-
sure in this study was at least 1000-fold
higher than in the present studies.
When animals are exposed to test
chemicals, it is possible that toxic effects on
organs (e.g., the liver) other than the testis
or reproductive axis could lead to a reduc-
tion in testicular size and thus daily sperm
production as a result of nonspecific
effects. Although this possibility cannot be
excluded completely, the present data on
bodyweight and kidneyweight provide lit-
tle evidence for any such effect-indeed, in
most instances treated animals were larger
than the controls. The exception was ani-
mals exposed to DES (positive controls),
which showed consistent evidence ofsome-
Table 6. Estimation of the nominal intake of
octylphenol (OP) and butyl benzyl phthalate (BBP)
between birth and day21 of postnatal life, based on
water consumption in study3(means ± SD, N=6)
Nominal
Water mean intake
Treatment Days intake of chemical
group (pg/I) postnatala (ml/48 hr) (pg/kg/day)b
Control 1 + 2 75 ± 22
10+ 11 182±55 -
20+21 243±72
OP(1000) 1+ 2 90 ± 36 129
10+ 11 216±42 309
20 + 21 257 ±69 367
BBP (1000) 1 + 2 88 ±24 126
10 + 11 192 ±64 274
20 + 21 256 ±43 366
aMeasurements of water intake were made every
48 hr; hence values are for 2 successive days.
bAssumes a body weight of 350 g for lactating
females.
what lower body weights. The explanation
for this effect is not clear from the present
studies, but it is likely that lactation may
have been impaired by DES (36). Ifthis is
the case, it is somewhat puzzling why there
was no evidence for such effects in animals
exposed to any ofthe estrogenic chemicals,
as these caused equal, or even larger, reduc-
tions in testicular weight than did DES
exposure. This discrepancy could reflect
differences in the pharmacokinetics of the
chemicals compared with DES.
Although the estrogenic chemicals test-
ed in the present studies exerted similar
effects on testis size and daily sperm pro-
duction, no evidence is provided that these
effects resulted specifically from the estro-
genicity ofthese compounds. The fact that
treatment with OPP caused a similar
reduction in testicular size as did treatment
with OP, despite the fact that OP is non-
estrogenic in vitro (14), could be interpret-
ed as evidence against estrogenicity per se
being a common causal mechanism.
However, it is possible that, when ingested,
OPP is metabolized such that the five
ethoxylate groups are cleaved, resulting in
the formation ofOP. This interpretation is
supported by the observation that, whereas
short-chain alkylphenol polyethoxylates
(such as OPP) do not bind to the estrogen
receptor in cell-free systems (14), they are
estrogenic in cell-based in vitro assays
(13,14) and in vivo (34). It will be impor-
tant in future studies to establish unequivo-
cally whether only estrogenic chemicals are
able to reduce testicular size and daily
sperm production in the manner described
here.
Irrespective ofwhether the reduction in
testis size and daily sperm production
caused by developmental exposure to OP
or BBP resulted from their estrogenicity,
the key question is whether these effects
have relevance to humans. This is a com-
plex issue which requires detailed
dose-response data and measurement of
the actual levels ofthe administered chemi-
cals in the male rats. It would be appropri-
ate to consider whether the nominal level
of exposure of rats to OP and BBP in the
present studies (which is presumed to be an
overestimate ofactual exposure levels) bears
any relationship to the equivalent level of
human exposure. There are little or no data
specifically for OP, but there is some infor-
mation on the environmental levels of the
class of compounds to which OP belongs,
namely, alkylphenol polyethoxylates, sever-
al ofwhich have been shown to be estro-
genic (14). Reported levels of these com-
pounds in river water vary from the low
micrograms per liter (37) to tens and hun-
dreds of micrograms per liter (23,24),
which approach the nominal levels ofexpo-
sure in the present study. Even tapwater
has been reported to contain estrogenic
degradation products of both nonylphenol
ethoxylate and octylphenol ethoxylate (38),
although the combined concentration was
only about 1 pg/l. However, as alkylphenol
polyethoxylates are used widely in industri-
al and some household detergents and
cleaners, in certain plastics, and in many
other ways, human exposure via routes
other than drinking water are likely.
In the case of BBP, there is more evi-
dence for concern about the possible risk to
human health. BBP and other phthalates
are the most ubiquitous ofall environmen-
tal contaminants, primarily because oftheir
use as plasticizers, and human exposure is
likely to be high (25,39,40). For example, a
recent study reported levels ofBBP alone as
high as 47.8 mg/kg in some foil-wrapped
butters (41), which would mean that inges-
tion of 50 g/day ofsuch butter by a 60-kg
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woman would lead to an intake ofapproxi-
mately 40 pg/kg/day, which approaches the
nominal intake values in the present study.
As the levels of total phthalates in other
dairy produce can exceed 50 mg/kg
(42,43), and there are many other possible
sources of human exposure to these com-
pounds, the present findings suggest that
further studies of the estrogenicity of
phthalates should be a priority. There is
already a huge literature on the toxicity of
phthalates, including their testicular toxici-
ty, but few of the published studies have
been able to detect developmental effects
similar to those reported here. This is
borne out by the reported no-observed
effect level (NOEL) of BBP for testicular
toxicity in rats of 125-150 mg/kg/day
(44,45). The fact that, in the present stud-
ies, nominal intake of 300-fold lower
amounts than the NOEL resulted in
around a 10% decrease in testicular weight
in two separate studies with a commensu-
rate fall in daily sperm production, argues
further that the cause ofthese decreases dif-
fers from the previously reported toxic
effects ofthese compounds on the testis.
The present data do not provide direct
evidence ofa link between human exposure
to environmental estrogens and falling
sperm counts in men. However, the find-
ings do provide some preliminary, indirect
evidence that exposure of rats to certain
environmental estrogenic chemicals during
gestation or neonatal life can result in
reduced testicular size and sperm produc-
tion in adulthood. As these effects occurred
in rats after only 3-9 weeks of exposure,
whereas in men the corresponding window
of development (and Sertoli cell prolifera-
tion) spans several years, there is at least the
theoretical possibility that similar effects in
men might be of larger magnitude than
those described here for the rat. However,
considerably more work, particularly in
establishing the likely level ofhuman expo-
sure to estrogenic chemicals, will be neces-
sary ifthe risk to man from such exposure
is to be assessed with any accuracy.
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